Z13.228 — Encounter for screening for other metabolic disorders
ICD-10-CM
Prior Authorization
No Prior Auth Required
No active coverage policies found for this code (low confidence)
Documentation Required
- For any iontophoretic dermatologic or ophthalmologic application: documentation of agent(s) used, concentrations, device/model, current and duration parameters, and monitoring for local adverse effects (erythema, burns, corneal complications, etc.).
- No documentation requirements are stated in this document chunk (bibliography).
- For primary focal hyperhidrosis: documentation that the member is unresponsive to or unable to tolerate oral pharmacotherapy for excessive sweating (examples given: anti-cholinergics, beta-blockers, benzodiazepines).
- For primary focal hyperhidrosis: documentation that significant disruption of professional and/or social life has occurred because of excessive sweating.
Key Coverage Criteria
- (Inferred from references) Iontophoresis for treatment of rheumatoid arthritic knees
- (Inferred from references) Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus
- (Inferred from references) Whole-finger iontophoresis to increase blood flow in systemic sclerosis
- (Inferred from references) Transdermal iontophoretic drug delivery platforms/technologies (general)
- (Inferred from references) Conservative treatments, including iontophoresis, for patellar tendinopathy
- (Inferred from references) Alternatives to oral opioids for cancer/postoperative pain including fentanyl iontophoretic transdermal system (ITS)
2 Active Policies
CIGNA-0398 — Transvaginal Ultrasound, Non-Obstetrical - (0398)
AETNA-CPB-0229 — Iontophoresis
Related Codes
Have a follow-up question?
Ask Verity about documentation requirements, denial risks, or coverage in your state.